Clinical Trial Update: Residual Inflammatory Risk-Guided colcHicine in Elderly Trial [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update exploring residual inflammatory risk-guided colchicine in elderly patients undergoing percutaneous coronary intervention for mul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Elderly Patient Conditions
• Multivessel Coronary Artery Disease
• Percutaneous Coronary Intervention

Drugs mentioned

• COLCHICINE (Colchicine)

Snippet

Sponsor: Chinese Academy of Medical Sciences, Fuwai Hospital | Conditions: Percutaneous Coronary Intervention, Multivessel Coronary Artery Disease | Phase 4 | Status: UNKNOWN